| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3331777 | Hematology/Oncology Clinics of North America | 2009 | 30 Pages |
Abstract
Bone marrow evaluation plays a critical role in staging and predicting prognosis in patients with Hodgkin lymphoma or non-Hodgkin lymphoma. Bone marrow can be the initial site of detection of lymphoma in patients with unexplained symptoms or cytopenias. A comprehensive evaluation of bone marrow includes complete blood counts, blood morphology, bone marrow aspirate, and generous core biopsy sections. Specialized testing should be used in a logical fashion on a case by case basis.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Qian-Yun Zhang, Kathryn Foucar,